The Scientist Connection

I am writing to you to make you aware of an extremely positive outcome resulting from your journal's 1999 story on researching heavy metal contamination in arctic whales, by A.J.S. Rayl.1 The content of the story led to inquiries from other scientists around the country interested in global oceanic toxicology. John Wise of Yale University and others contacted me, and as a result, a network of researchers is beginning to form to address, in a global manner, the seriousness of our situation. �

Written byThomas Goodwin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I am writing to you to make you aware of an extremely positive outcome resulting from your journal's 1999 story on researching heavy metal contamination in arctic whales, by A.J.S. Rayl.1 The content of the story led to inquiries from other scientists around the country interested in global oceanic toxicology. John Wise of Yale University and others contacted me, and as a result, a network of researchers is beginning to form to address, in a global manner, the seriousness of our situation.

Funding for marine toxicology has been, and at this point remains, severely limited due to a lack of understanding regarding how oceanic toxicology affects the human condition. Only when the realization that humans consume the same lower level food animals as the great marine mammals will there be a change in our perspective regarding how these systems may serve as bioreporters for our overall human health. It is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies